Yes, COVID-19 is treatable. Most people recover at home with rest and basic symptom relief, and for those at higher risk of severe illness, prescription antiviral medications can shorten the duration and reduce the chance of hospitalization. The treatment options available today look very different from the early pandemic, when supportive care in a hospital was often the only option.
Antiviral Medications for High-Risk Patients
Two oral antiviral drugs are currently authorized for treating mild to moderate COVID-19 in people who are more likely to get very sick: Paxlovid and Lagevrio (molnupiravir). Both are taken at home as pills over five days. Paxlovid is approved for adults and children aged 12 and older, while Lagevrio is approved only for adults.
These medications work by interfering with the virus’s ability to copy itself inside your cells. Paxlovid, for example, blocks an enzyme the virus needs to process its own proteins during replication. Without that enzyme functioning, the virus can’t assemble the components it needs to spread to new cells. The key constraint is timing: treatment must start within five days of your first symptoms. The sooner you begin, the more effective it is, so testing early matters.
Not everyone qualifies for these antivirals. They’re targeted at people with a higher risk of progressing to severe disease, which includes older adults, people with weakened immune systems, and those with chronic conditions like heart disease, diabetes, or obesity. If you’re otherwise healthy and young, your doctor will likely recommend managing symptoms at home without prescription antivirals.
What Rebound Looks Like After Paxlovid
Some people who take Paxlovid experience a return of symptoms or a positive test result after initially improving. Observational studies have found rebound rates between roughly 7% and 14%, depending on the study. Symptoms typically return 3 to 7 days after the initial illness resolves, with the median time to viral rebound landing around 9 days after diagnosis. The rebound illness tends to be mild, and in outpatient studies, no hospitalizations or deaths were reported among people who experienced it. Rebound generally resolves on its own within about a week.
Treatment for Hospitalized Patients
When COVID-19 progresses to the point where someone needs hospital care, the treatment approach shifts. An intravenous antiviral called remdesivir is used for hospitalized patients who need supplemental oxygen but aren’t yet on a ventilator. In a major clinical trial of over 1,000 hospitalized adults, patients receiving this drug recovered in a median of 10 days compared to 15 days with a placebo, and their hospital stays were about 5 days shorter.
For patients whose oxygen levels drop significantly or who develop serious lung inflammation, doctors add a corticosteroid to reduce the immune system’s overreaction to the virus. A landmark trial found that this approach reduced mortality in patients requiring oxygen therapy or mechanical ventilation. In cases where inflammation continues to escalate despite the corticosteroid, a second type of immune-modulating medication can be added. This drug works by dialing down the signaling pathways that drive excessive inflammation, essentially calming the immune system’s overresponse that can damage the lungs and other organs.
One category of treatment that played an important role earlier in the pandemic, monoclonal antibodies, is no longer used in clinical practice. These lab-made antibodies were designed to neutralize specific versions of the virus, but as new variants emerged, the virus evolved to evade them. The antibody combinations that were once standard treatments lost their effectiveness against Omicron and subsequent variants.
Home Recovery for Most People
The majority of COVID-19 cases are mild to moderate and resolve without prescription treatment. Managing symptoms at home typically means the same approach you’d use for a bad cold or the flu: over-the-counter pain relievers and fever reducers, plenty of fluids, and rest. Most people feel significantly better within a week or two, though fatigue can linger somewhat longer.
If your symptoms worsen after the first few days, particularly if you develop difficulty breathing, persistent chest pain, or confusion, that’s a signal to seek medical attention promptly. COVID-19 tends to follow a pattern where the first week involves direct viral symptoms (fever, cough, body aches), and in some cases, the second week can bring a more serious inflammatory phase affecting the lungs.
Long COVID and Ongoing Symptoms
For some people, symptoms persist well beyond the initial infection, a condition commonly called long COVID. Fatigue, brain fog, shortness of breath, and exercise intolerance are among the most commonly reported ongoing problems. There is no single treatment that resolves long COVID, and management focuses on addressing whichever symptoms are most disruptive to daily life.
Doctors typically build a rehabilitation plan tailored to the individual, borrowing symptom management strategies from conditions that share similar features, such as chronic fatigue syndrome, fibromyalgia, and disorders of the autonomic nervous system (which controls heart rate, blood pressure, and digestion). A particularly important consideration is post-exertional malaise, where physical or mental effort triggers a worsening of symptoms. For people experiencing this, a careful, paced approach to activity is more effective than pushing through. Tracking symptoms in a diary helps both patients and their doctors identify patterns and adjust the plan over time.
Early antiviral treatment during the acute infection may reduce the likelihood of developing long COVID, which is another reason prompt testing and treatment matter for people who qualify.